Search Results for "vol"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for vol. Results 321 to 330 of 1520 total matches.
Carboplatin
The Medical Letter on Drugs and Therapeutics • Sep 08, 1989 (Issue 800)
, 12 suppl A:67, 1985).
The Medical Letter, Vol. 31 (Issue 800) September 8, 1989, pp. 83-84 ...
Carboplatin (Paraplatin - Bristol-Myers), a cytotoxic platinum-containing drug chemically related to cisplatin (Platinol), was recently approved by the US Food and Drug Administration (FDA) for palliative treatment of patients with recurrent ovarian cancer, including those previously treated with cisplatin.
Levamisole With Fluorouracil For Colon Cancer
The Medical Letter on Drugs and Therapeutics • Oct 06, 1989 (Issue 802)
-year survival rate (roughly 50% vs 40% for untreated patients) that
The Medical Letter, Vol. 31 (Issue ...
Levamisole (Janssen), an old antiparasitic drug widely used for treatment of ascariasis in animals, is now available from the National Cancer Institute (NCI) for investigational use with fluorouracil (5-FU; Adrucil; and others) as an adjuvant for treatment of resectable colon cancer that has metastasized to regional lymph nodes (Dukes stage C).
Ibuprofen vs. Acetaminophen in Children
The Medical Letter on Drugs and Therapeutics • Dec 15, 1989 (Issue 807)
renal toxicity with acute overdosage and possibly with prolonged use.
The Medical Letter, Vol. 31 ...
Since the implication of aspirin in Reye's syndrome, acetaminophen (Tylenol; and others) has become the standard drug for symptomatic treatment of fever and pain in children. Ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID) available for many years in tables (Mortin; Advil; and others), has now become available in a suspension. The suspension will be sold by presecription for treatment of fever or arthritis in children.
Propafenone for Cardiac Arrhythmia
The Medical Letter on Drugs and Therapeutics • Apr 20, 1990 (Issue 816)
, Vol. 32 (Issue 816) April 20, 1990, pp. 37-38
Copyright The Medical Letter
UNAUTHORIZED FORWARDING ...
Propafenone (Rythmol - Knoll), a class IC antiarrhythmic drug used in Europe for treatment of various arrhythmias for more than 10 years, was recently marketed in the USA for oral treatment of life-threatening ventricular arrhythmias such as sustained ventricular tachycardia. This restrictive labeling reflects concerns arising from the interim report of the Cardiac Arrhythmia Suppression Trial, in which post-myocardial infarction patients with asymptomatic or mildly symptomatic ventricular arrhythmias treated with the class IC antiarrhythmic drugs encainide (Enkaid) or flecainide...
Cefmetazole Sodium (Zefazone)
The Medical Letter on Drugs and Therapeutics • Jul 13, 1990 (Issue 822)
(R Finch et al, eds, J Antimicrob Chemother, 23 suppl D, 1989). ProThe Medical Letter, Vol. 32 (Issue ...
Cefmetazole sodium (Zefazone - Upjohn), a second-generation parenteral cephalosporin, was recently marketed in the USA for intravenous (IV) treatment of various infections caused by susceptible organisms. Like cefotetan (Cefotan), cefamandole (Mandol), cefoperazone (Cefobid), and moxalactam (Moxam), cefmetazole contains a methylthiotetrazole group that has been associated with prothrombin deficiency.
Trimethoprim-Polymyxin B for Bacterial Conjunctivitis
The Medical Letter on Drugs and Therapeutics • Jul 27, 1990 (Issue 823)
.
The Medical Letter, Vol. 32 (Issue 823) July 27, 1990, pp. 71-72
Copyright The Medical Letter
UNAUTHORIZED ...
Bacterial infections of the conjunctivae are usually self-limited, but topical antimicrobial therapy can be helpful. A solution of trimethoprim sulfate 0.1% with polymyxin B sulfate 10,000 units/ml (Polytrim - Burroughs Wellcome, distributed by Allergan) was recently marketed in the USA for treatment of superficial ocular bacterial infections.
Botulinum Toxin for Ocular Muscle Disorders
The Medical Letter on Drugs and Therapeutics • Nov 02, 1990 (Issue 830)
, Vol. 32 (Issue 830) November 2, 1990, pp. 100-102
Copyright The Medical Letter
UNAUTHORIZED ...
Botulinum toxin Type A (Oculinum - Allergan), used investigationally for many years to treat ocular muscle disorders (Medical Letter, 29:101, 1987), has now been approved by the US Food and Drug Administration for intramuscular treatment of strabismus and blepharospasm in patients more than 12 years old.
Three New ACE Inhibitors For Hypertension
The Medical Letter on Drugs and Therapeutics • Sep 06, 1991 (Issue 852)
, diabetics with even mild renal impairment, and patients
The Medical Letter, Vol. 33 (Issue 852) September 6 ...
Benazepril (Lotensin - Ciba-Geigy), fosinopril (Monopril - Mead Johnson), and - Hoechst, Upjohn) are new angiotensin-converting enzyme (ACE) inhibitors recently approved by the US Food and Drug Administration (FDA) for once-a-day treatment of hypertension. Three other ACE inhibitors, captopril (Capoten), enalapril (Vasotec), and lisinopril (Prinivil, Zestril) were previously available in the USA for this indication. Captopril and enalapril have also been approved by the FDA for treatment of congestive heart failure.
Felodipine - Calcium-Channel Blocker For Hypertension
The Medical Letter on Drugs and Therapeutics • Dec 13, 1991 (Issue 859)
that 65 years old and those with
hepatic dysfunction.
The Medical Letter, Vol. 33 (Issue 859) December ...
Felodipine (Plendil - Merck), an extended-release preparation of a dihydropyridine calcium-channel blocker was recently marketed in the USA for oral treatment of hypertension. An immediate-release formulation is available in some other countries.
Capsaicin - A Topical Analgesic
The Medical Letter on Drugs and Therapeutics • Jun 26, 1992 (Issue 873)
was statistically significant (CL Deal et al, Clin Ther,
13:383, 1991).
The Medical Letter, Vol. 34 (Issue 873 ...
Capsaicin, a vanillyl alkaloid found in hot peppers and related plants, is now available without a prescription as Zostrix-HP (GenDerm) for topical relief of pain due to diabetic neuropathy, herpes zoster, or arthritis. The new formulation contains 0.075% capsaicin; the drug was previously available in a 0.025% concentration as Zostrix.